BE900481A - Composition et procede pour empecher ou inhiber la resorption d'os alvelolaire. - Google Patents

Composition et procede pour empecher ou inhiber la resorption d'os alvelolaire.

Info

Publication number
BE900481A
BE900481A BE0/213577A BE213577A BE900481A BE 900481 A BE900481 A BE 900481A BE 0/213577 A BE0/213577 A BE 0/213577A BE 213577 A BE213577 A BE 213577A BE 900481 A BE900481 A BE 900481A
Authority
BE
Belgium
Prior art keywords
preventing
composition
alvelolar
bones
inhibiting resorption
Prior art date
Application number
BE0/213577A
Other languages
English (en)
Inventor
Julius Wechter William
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24104966&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BE900481(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of BE900481A publication Critical patent/BE900481A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/52—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
    • C07C57/58—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Confectionery (AREA)
  • Dental Preparations (AREA)

Abstract

Composition pour empecher ou inhiber la résorption d'os alvéolaire, comprenant une certaine quantité d'un composé choisi parmi l'ibuprofène ou le fluorbiprofène, ou d'un sel ou ester alkylique inférieur en C1-C6 pharmaceutiquement acceptable de ceux-ci, laquelle quantité est non antiinflammatoire et efficace dans la prévention ou l'inhibition de la résorption d'os alvéolaire, ainsi qu'un support pharmaceutiquement acceptable, et utilisation de cette composition.
BE0/213577A 1983-08-31 1984-08-31 Composition et procede pour empecher ou inhiber la resorption d'os alvelolaire. BE900481A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52827283A 1983-08-31 1983-08-31

Publications (1)

Publication Number Publication Date
BE900481A true BE900481A (fr) 1985-02-28

Family

ID=24104966

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/213577A BE900481A (fr) 1983-08-31 1984-08-31 Composition et procede pour empecher ou inhiber la resorption d'os alvelolaire.

Country Status (5)

Country Link
EP (1) EP0137668B2 (fr)
JP (1) JPH0647532B2 (fr)
BE (1) BE900481A (fr)
DE (2) DE3428729A1 (fr)
IT (1) IT1174649B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4843099A (en) * 1987-07-20 1989-06-27 Colgate-Palmolive Company Device and composition for treatment of the gums

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4753801A (en) * 1985-10-25 1988-06-28 Eli Lilly And Company Sustained release tablets
GB8528195D0 (en) * 1985-11-15 1985-12-18 Boots Co Plc Therapeutic compositions
JPH0435640Y2 (fr) * 1985-11-22 1992-08-24
WO1987004618A1 (fr) * 1986-01-30 1987-08-13 University Of Utah Traitement de l'osteoporose
DE3621036A1 (de) * 1986-06-24 1988-01-07 Merckle Gmbh Fluessige ibuprofen-zubereitungen
US4684666A (en) * 1986-08-19 1987-08-04 Haas Pharmaceuticals, Inc. Stabilized liquid analgesic compositions
EP0321505A1 (fr) * 1986-10-22 1989-06-28 The Upjohn Company Traitement des gingivites avec de l'ibuprofen ou du flurbiprofen
US5225441A (en) * 1987-06-18 1993-07-06 Block Drug Company, Inc. Treatment of periodontal disease
ES2058288T3 (es) * 1987-07-08 1994-11-01 American Home Prod Composiciones de ibuprofen secadas por atomizacion.
US4859704A (en) * 1987-10-15 1989-08-22 Oratech Pharmaceutical Development Corporation Water soluble ibuprofen compositions and methods of making them
US4861797A (en) * 1987-10-15 1989-08-29 Oratech Pharmaceutical Development Corporation Liquid ibuprofen compositions and methods of making them
US4931220A (en) * 1987-11-24 1990-06-05 Ppg Industries, Inc. Organic photochromic pigment particulates
US4933172A (en) * 1988-10-06 1990-06-12 Warner-Lambert Co. Method of and compositions for treating destructive periodontal disease
ATE117892T1 (de) * 1989-08-17 1995-02-15 Sepracor Inc Orales s(+)-flurbiprofen- oder ketoprofenhaltiges mittel.
US5190981A (en) * 1989-08-17 1993-03-02 Sepracor Inc. Formulation containing S(+) enantiomer of flurbiprofen or ketoprofen and method of use for oral administration for prevention and treatment of bone loss associated with periodontal disease
DE3938227C1 (en) * 1989-11-17 1991-05-02 Dolorgiet Gmbh & Co Kg, 5205 St Augustin, De Oral antiinflammatory and analgetic pharmaceutical compsn. - comprises magnesium ibuprofen dissolved in mixt. of water, propane-1,2-diol and glycerol
US5464609A (en) * 1990-03-16 1995-11-07 The Procter & Gamble Company Use of ketorolac for treatment of oral diseases and conditions
WO1994001097A1 (fr) * 1992-07-01 1994-01-20 Sankyo Company, Limited Composition pour application bucale, contenant un derive de polyprenyle comme ingredient actif
WO1994024990A1 (fr) * 1993-04-27 1994-11-10 Sunstar Inc. Composition intra-orale
GB9523833D0 (en) * 1995-11-22 1996-01-24 Boots Co Plc Medical treatment
US5902110A (en) * 1995-12-18 1999-05-11 The Block Drug Company Bone regeneration
US6342530B1 (en) * 2000-11-14 2002-01-29 Farmacon-Il, Llc Composition and method for parenteral administration of ibuprofen d,l- or l-lysine salt
US7846422B2 (en) 2003-08-04 2010-12-07 Kao Corporation Method for prevention or treatment of periodontal diseases and composition for an oral cavity
FR2865648B1 (fr) 2004-02-03 2006-06-30 Philippe Perovitch Procede de diffusion de molecules insolubles en milieu aqueux et composition mettant en oeuvre ce procede
SG177354A1 (en) 2009-07-01 2012-02-28 Dexcel Pharma Technologies Ltd Local therapeutic release device
US8865198B2 (en) 2010-10-25 2014-10-21 Dexcel Pharma Technologies Ltd. Method for treating a periodontal disease
AU2012362898B2 (en) * 2011-12-28 2017-11-09 Amgen, Inc. Method of treating alveolar bone loss through the use of anti-sclerostin antibodies
EP2809306A2 (fr) 2012-01-31 2014-12-10 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Nouvelles compositions pharmaceutiques de flurbiprofène et glucosamine
US20150359814A1 (en) 2013-01-28 2015-12-17 Sanovel Ilac Sanayi Ve Ticaret A.S. Pharmaceutical Combinations of Flurbiprofen, Glucosamin and Capsaicin
JP6315741B2 (ja) * 2015-08-18 2018-04-25 合同会社Ｐｈａｒｍａ Ｓｅｅｄｓ Ｃｒｅａｔｅ ＮＳＡＩＤｓまたはヘパリン類含有口腔用組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4346108A (en) * 1981-06-22 1982-08-24 The Upjohn Manufacturing Company M Method for preventing adhesion formation
EP0070714B1 (fr) * 1981-07-20 1986-05-07 The Upjohn Company Utilisation d'ibuprofen ou de flurbiprofen pour la préparation d'un médicament pour traitement de dérangements respiratoires

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4843099A (en) * 1987-07-20 1989-06-27 Colgate-Palmolive Company Device and composition for treatment of the gums
EP0300277A3 (fr) * 1987-07-20 1989-08-02 Colgate-Palmolive Company Dispositif et produits de traitement des gencives

Also Published As

Publication number Publication date
DE3428729A1 (de) 1985-04-18
EP0137668A3 (en) 1985-06-05
IT8422312A0 (it) 1984-08-10
JPH0647532B2 (ja) 1994-06-22
EP0137668B2 (fr) 1993-03-17
EP0137668B1 (fr) 1990-01-17
DE3481035D1 (de) 1990-02-22
IT1174649B (it) 1987-07-01
EP0137668A2 (fr) 1985-04-17
JPS6061524A (ja) 1985-04-09

Similar Documents

Publication Publication Date Title
BE900481A (fr) Composition et procede pour empecher ou inhiber la resorption d'os alvelolaire.
IL103941A (en) Sex steroid activity inhibitors and pharmaceutical compositions containing them
EP0193148A3 (fr) 2-(Acyl contenant un alcoxy)hydrazides de l'acide 8-chlorodibenzo[B,F][1,4]oxazazépine-10(11H)carboxylique
ATE89731T1 (de) Zusammensetzungen zur propylaktischen behandlung von osteitis und osteomyelitis.
CA2034912A1 (fr) Composition deglacante inhibitrice de corrosion et methode d'utilisation
RU94045280A (ru) Средство для ингибирования патологических состояний молочных желез
ATE163850T1 (de) Pharmazeutische zusammensetzungen von 5ht1 agonistischen alkyl sulphonamidenfür rektale verabreichungen
HUT73231A (en) Pharmaceutical compositions with 17-beta-monosubstituted-carbamoyl-4-aza-5-alpha-androst-1-en-3-ones for treatment of chronic prostatitis
AU562024B2 (en) (hydroxypropyl) phenoxy (propyl) piperidine
RU98118188A (ru) Серосодержащие производные с ретроамидной связью в качестве ингибиторов эндотелинпревращающих ферментов
FR2622443B1 (fr) Agent contenant un compose organogermanium pour ameliorer les fonctions des organes reduites par une inhibition de la circulation du sang
FR2403798A1 (fr) Compositions synergiques a base de disulfure de bis(2-pyridyl-1-oxyde et leur utilisation pour leur activite anti-inflammatoire
GR79152B (fr)
BE901879A (fr) Produits analogues de la 1alpha-hydroxyvitamine d2, leur procede de preparation et compositions pharmaceutiques les renfermant.
FI834796A0 (fi) Foerfarande foer framstaellning av 4-hydroxi-benzhydroler
ES8506660A1 (es) Un procedimiento para la preparacion de un compuesto de b-lactama

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: THE UPJOHN CY

Effective date: 19920831